CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. The governor also signed Senate Bill 1700 to protect the privacy of doctors recommending low-THC marijuana and their patients.

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Position Requirements.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Law Report

AUGUST 10, 2021

The acquisition combines proven high quality dried flower sales and industry-leading yields with immediate facility expansion, increased capacity, enhanced product development, key sales licences, existing provincial supply deals, and direct distribution to medical patients focused on Veterans. MONTRÉAL, Aug. providing approx.

Seed-To-Sale 105

Seed-To-Sale Cultivation Patients Cannabis 105

WeedAdvisor

AUGUST 2, 2019

Jamaica’s legalization of medical marijuana was a huge stepping stone for the country, which has been plagued by a massive black market and 50,000 patients seeking marijuana for treatment. Demand will not be as heavy as Canada, which hosts hundreds of thousands of medical cannabis patients, compared to only about 50,000 in Jamaica.

Dispensary 49

Dispensary Compliance Compliance Retail 49

Cannabis Law Report

FEBRUARY 17, 2022

WORCESTER – The Cannabis Control Commission (Commission) is alerting patients and consumers to its quarantine order (Order), issued October 18, 2021, mandating that ACK Natural, LLC, a colocated medical- and adult-use licensee, recall all products with unverifiable mycotoxin test results sold to its consumers and patients.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

Cannabis Law Report

FEBRUARY 17, 2020

I am a legal Florida medical marijuana patient since January 2017, as well as a traveling medical cannabis writer, patient educator and vocal advocate. I am a legal Florida medical marijuana patient since January 2017, as well as a traveling medical cannabis writer, patient educator and vocal advocate.

Dispensary 76

Dispensary Patients Agriculture Conditions 76

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. The immediate next steps are to submit data for ethics committee review and approval whereupon acceptance, further details will be provided. “A

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

Cannabis Law Report

SEPTEMBER 23, 2021

Tracking recent data from within the last year (following the publication of the DEA Interim Final Rule which added confusion to the delta-8 legality question), more than a dozen hospital or emergency room visits and hundreds of calls to poison control were reported. Delta-8 THC products should be kept out of the reach of children and pets.

THC 52

THC Concentrates Pets DEA 52

Cannabis Law Report

JULY 30, 2019

The ASA highlights that it takes the FDA “an average of 9 years to approve any drug, but it only takes approximately two to four weeks for a medical cannabis patient with chronic pain to be approved by a state program.” ” These patients then have access to purchasing the substance from a regulated state dispensary.

Marijuana 40

Marijuana Education Patients Research and Development 40

Cannabis Law Report

JULY 23, 2019

Businesses preparing to market a new product nationally must follow the rules of trademark law as well as marketing and advertising claims under state and US laws when creating a trademark, advertising copy and copyright-registered packaging for the product. This is particularly the case for cannabis and cannabidiol (CBD) products.

Law 40

Law Clinical Trials CBD Edibles 40

Cannabis Law Report

AUGUST 19, 2019

To date, only one cannabis-based medicinal product, Sativex, (for the treatment of multiple sclerosis) has been licensed by the MHRA. No data is available regarding prescriptions written in respect of secondary care. The Regulations define a CBPM as a preparation or product that. (a) Novel Foods Regulation.

Environment 45

Environment Food Seed-To-Sale Medicine 45

Veriheal

AUGUST 31, 2021

The app would also provide data to producers and distributors to identify trends in the market to better serve the needs of consumers. . She provides clear strategies for teaching healthcare professionals how to improve their proficiency and cultural competency for caring for medical marijuana patients. Camille Elliott.

Research and Development 117

Research and Development Supply Chain Programs Education 117

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

CannaMD

MAY 14, 2020

CannaMD has contacted Florida’s leading medical marijuana treatment centers (MMTCs) , who say they’re now just waiting on the Department of Health to issue rules regarding packaging and other essential requirements. Safety of production and packaging. Why Do People Like Marijuana Edibles?

Edibles 105

Edibles Marijuana THC Vaping 105

Cannabis Law Report

JANUARY 9, 2019

Now the former finance executive is on a mission to stamp out diabetes in some of the world’s worst-hit areas with a revolutionary marijuana treatment engineered by his firm, Phoenix Life Sciences International. It showed us there were ways to have formulas that were more effective for diabetes, and others for the treatment of cancers.”.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

SpeedWeed

JULY 19, 2021

The data contained in that report has rocked the cannabis vaping world. The data was far worse than he imagined. Phytol, according to the data in the study, appeared unsafe to inhale. Until then, there was no data comparing the toxicity of inhaled phytol versus propylene glycol (PG). Its contents floored him.

Vaping 52

Vaping Terpenes Data Research and Development 52

Puff Puff Post

NOVEMBER 5, 2019

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa (“EB”). It may also potentially address the underlying disease by enhancing skin integrity in a subset of EB Simplex patients. For more information, visit www.inmedpharma.com. About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Puff Puff Post

NOVEMBER 5, 2019

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa (“EB”). It may also potentially address the underlying disease by enhancing skin integrity in a subset of EB Simplex patients. For more information, visit www.inmedpharma.com. About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

Cannabis Law Report

NOVEMBER 15, 2021

We are looking forward to the completion of the required IND enabling studies and submitting our IND package to the FDA in anticipation of first-in-human trials,” continued Mr. Mack. RECENT DEVELOPMENTS. On July 30, 2021, Virpax announced the appointment of Gerald W. Bruce and Michael F. Dubin, CPA to its Board of Directors.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. Obviously, that means that there are more patients and there are more products to sell. You can open up the market for them.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

SEPTEMBER 19, 2019

The combination of New Yorkers and a innefficient track n trace may make us want to write a treatment for Netflix, it’ll be a six parter and will probably run at least 10 seasons ! She worries the additional regulation, with its extra costs and labor, will drive smaller caregivers out of business, which will end up hurting patients.

Retail 40

Retail Policy Vaping Programs 40

Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

As policies become more data-driven and progressive, cultivation and production technologies have continued to improve drastically over the past several years. The governor of Alabama signed a recreational bill into law in 2021, but patients will likely not have access to retail products until 2022. each year since 2019.

Recreational 52

Recreational Data DEA Cannabis 52

Cannabis Law Report

JULY 12, 2019

Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

JULY 4, 2019

California cannabis packaging regulations will require all vaporizer cartridges to display the state’s version of the industry’s universal symbol. The state began accepting formal applications for medical cannabis patients on June 28. percent of the state’s population has already registered as patients.

Research and Development 40

Research and Development Banking Hemp Legislation 40

Cannabis Law Report

MARCH 2, 2020

After the thermal treatment, the green hardware is physically separated. Recycle kits include everything you need to package your batteries for proper shipment.” Some of them even reach an astonishing 96% recycling efficiency, but the aim is to raise the bar higher in the future. ” What about sustainability in the U.S.

Vaping 59

Vaping Collective Research and Development Packaging 59

Cannabis Law Report

OCTOBER 17, 2019

Selinger cites software, point-of-sale systems, and packaging as areas that are thriving in the state. Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. billion in 2025, according to Grandview Research.

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

MARCH 26, 2019

It was disappointing to see Law Enforcement advocating for policy that continues to saddle Texans with criminal records and all those collateral consequences as well as putting fear ahead of regulated patient access to medical marijuana. Please take action and let your legislators know that you support common sense policy!

Marijuana 252

Marijuana Decriminalization Policy Legislation 252

Cannabis Law Report

MAY 14, 2022

Senator Patty Murray (D-WA) is currently leading a push to include it in a sweeping package intended to help resolve the country’s ongoing supply chain issues. Further, despite fears that recreational sales might threaten the supply for medicinal users, state data reveals that the medicinal market remained stable. Dentons Speaks.

Banking 52

Banking Recreational Research and Development Cannabis 52